Journal rankings · indicator year 2006
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2006
Cellular and Molecular Neuroscience journal rankings 2006
32 ranked journals · Subfield in Neuroscience
Cellular and Molecular Neuroscience has 32 ranked journals in 2006. The median journal has an OJR of 0.91, below the world average of 1.00, up 0.02 on 2005; Q1 starts at OJR 1.41. The top three are Brain Research Reviews, NeuroRx, and Neuropsychopharmacology.
Ranks and citation indicators: 2006. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2003–2005, the window the 2006 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Neuroscience (8)
32 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2005. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2003–2005, the window the 2006 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2003–2005 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2006. | Compare |
|---|---|---|---|---|---|---|---|
1Brain Research ReviewsElsevier BV · Netherlands | 3.06Q1 | 6.83 0.23 up from 2005 | 281 | 13% | — | ||
2NeuroRxSpringer Nature · United States | 2.85Q1 | 6.55 4.04 up from 2005 | 102 | 67% | — | ||
3NeuropsychopharmacologySpringer Nature · United States | 2.14Q1 | 5.83 0.25 up from 2005 | 848 | 21% | $5,290 | ||
4PsychopharmacologySpringer Science+Business Media · Germany | 1.51Q1 | 4.43 0.07 up from 2005 | 1,253 | 16% | $4,390 | ||
5Critical Reviews in NeurobiologyBegell House · United States | 1.50Q1 | 3.51 0.14 down from 2005 | 44 | 5% | — | ||
6CNS Drug ReviewsWiley · United States | 1.44Q1 | 3.24 0.09 down from 2005 | 60 | 94% | — | ||
7NeuropharmacologyElsevier BV · Netherlands | 1.43Q1 | 4.32 0.24 up from 2005 | 806 | 6% | $4,300 | ||
8The Journal of Comparative NeurologyWiley · United States | 1.41Q1 | 4.32no change | 1,331 | 25% | $5,450 | ||
9Journal of NeurobiologyWiley · United States | 1.40Q2 | 3.97 0.04 up from 2005 | 393 | 10% | — | ||
10Journal of Neuroscience ResearchWiley · United States | 1.37Q2 | 4.11 0.52 up from 2005 | 1,079 | 12% | $4,840 | ||
11NeuropeptidesElsevier BV · United Kingdom | 1.07Q2 | 3.25 1.25 up from 2005 | 191 | 4% | $3,530 | ||
12SynapseWiley · United States | 1.04Q2 | 2.99 0.41 down from 2005 | 376 | 11% | $3,570 | ||
13Molecular Brain ResearchElsevier BV · Netherlands | 0.98Q2 | 2.49 0.22 up from 2005 | 964 | — | — | ||
14Pharmacology Biochemistry and BehaviorElsevier BV · United States | 0.93Q2 | 2.63 0.39 up from 2005 | 805 | 13% | $3,650 | ||
15Journal of Chemical NeuroanatomyElsevier BV · Netherlands | 0.93Q2 | 2.06 0.16 down from 2005 | 196 | 7% | $3,230 | ||
16AlcoholElsevier BV · United Kingdom | 0.92Q2 | 2.66 0.64 up from 2005 | 222 | 13% | $3,720 | ||
17Regulatory PeptidesElsevier BV · Netherlands | 0.90Q3 | 2.64 0.51 up from 2005 | 636 | 7% | — | ||
18Journal of Comparative Physiology ASpringer Science+Business Media · Germany | 0.90Q3 | 1.83 0.40 down from 2005 | 352 | 9% | $3,990 | ||
19Behavioural PharmacologyLippincott Williams & Wilkins · United Kingdom | 0.88Q3 | 2.44 0.28 up from 2005 | 231 | 4% | — | ||
20Journal of Neurosurgery PediatricsUnited States | 0.86Q3 | 2.32 1.02 up from 2005 | 92 | 2% | — | ||
21Pharmacology & ToxicologyWiley · Denmark | 0.83Q3 | 2.57 0.90 up from 2005 | 103 | — | — | ||
22The CerebellumSpringer Science+Business Media · United Kingdom | 0.80Q3 | 2.46 0.82 up from 2005 | 114 | 4% | $4,790 | ||
23Addiction BiologyOAWiley · United Kingdom | 0.76Q3 | 2.34 0.37 up from 2005 | 134 | 6% | $3,150 | ||
24Developmental Brain ResearchElsevier BV · Netherlands | 0.75Q3 | 1.81no change | 605 | — | — | ||
25Journal of NeurocytologySpringer Nature · Netherlands | 0.73Q4 | 1.97 0.15 down from 2005 | 168 | 43% | — | ||
26Brain Research ProtocolsElsevier BV · Netherlands | 0.71Q4 | 1.79 0.08 up from 2005 | 150 | — | — | ||
27Child s Nervous SystemSpringer Science+Business Media · Germany | 0.57Q4 | 1.19 0.06 up from 2005 | 533 | 5% | $4,790 | ||
28min - Minimally Invasive NeurosurgeryThieme Medical Publishers (Germany) · Germany | 0.51Q4 | 1.06 0.02 down from 2005 | 235 | 2% | — | ||
29Neuron Glia BiologyCambridge University Press · United Kingdom | 0.50Q4 | 1.54 0.40 up from 2005 | 52 | 56% | — | ||
30Journal of NeurogeneticsTaylor & Francis · Switzerland | 0.44Q4 | 1.71 0.74 up from 2005 | 41 | 0% | — | ||
31Cerebrospinal Fluid ResearchOABritish Motor Corporation · United Kingdom | 0.21Q4 | 0.44 0.26 up from 2005 | 138 | 100% | $1,680 | ||
32Neuroscience Research CommunicationsWiley · United Kingdom | 0.09Q4 | 0.28 0.08 up from 2005 | 66 | — | — |
Subfields of Neuroscience, with Cellular and Molecular Neuroscience highlighted.
- Cognitive Neuroscience177
- Cellular and Molecular Neuroscience32
- Neurology10
- Sensory Systems4
- Behavioral Neuroscience3
- Biological Psychiatry2
- Endocrine and Autonomic Systems2
- Developmental Neuroscience1
Journals
Citations made in 2006. Corpus-wide, 71.3% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
3 additional Cellular and Molecular Neuroscience journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2003–2005, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2006. Publication window: 2003–2005. How these summaries are calculated
- Ranked journals
- 32
- Window papers (baseline)
- 38,289 +0.9% from indicator year 2003
- Median OJR
- 0.91 +15.5% from indicator year 2003
- Rising journals (2025)
- 1
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2003–2005 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 27 | 27 | 26 | 27 | 27 | 32 | 32 | 32 | 31 | 27 | 30 | 32 | 33 | 32 | 30 | 30 | 32 | 32 | 29 | 32 | 33 | 33 | 33 | 32 | 31 | 30 | |
| Window papers (baseline) | 37,773 | 38,664 | 38,213 | 37,940 | 37,414 | 38,123 | 38,289 | 38,810 | 38,951 | 41,086 | 41,577 | 41,975 | 41,244 | 41,433 | 42,264 | 42,615 | 42,554 | 41,749 | 40,554 | 39,909 | 39,604 | 39,824 | 40,023 | 39,750 | 39,038 | 38,750 | |
| Median OJR | 0.73 | 0.74 | 0.83 | 0.790 | 0.86 | 0.894 | 0.91 | 0.885 | 0.94 | 1.16 | 1.18 | 1.12 | 1.07 | 1.147 | 1.14 | 1.153 | 1.13 | 1.149 | 1.146 | 1.04 | 1.004 | 0.997 | 0.93 | 0.88 | 0.90 | 0.791 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.